Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROSCIENCE
Volume 43, Issue 1, Pages 3-16
Publisher
Wiley
Online
2015-09-03
DOI
10.1111/ejn.13056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
- (2015) Thomas G. Beach et al. NEUROPATHOLOGY
- Immunotherapy for Alzheimer's disease
- (2014) Thomas Wisniewski et al. BIOCHEMICAL PHARMACOLOGY
- Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
- (2014) Christiane Reitz et al. BIOCHEMICAL PHARMACOLOGY
- Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
- (2014) Marcos J. Guerrero-Muñoz et al. BIOCHEMICAL PHARMACOLOGY
- Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins
- (2014) Dezerae Cox et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A Sensitive phage-based capture ELISA for sub-femtomolar detection of protein variants directly from biological samples
- (2014) Stephanie Williams et al. BIOTECHNOLOGY PROGRESS
- Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease
- (2014) Marta Swirski et al. Alzheimers Research & Therapy
- Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
- (2014) Natalia Salvadores et al. Cell Reports
- The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease
- (2013) Johanna L. Crimins et al. AGEING RESEARCH REVIEWS
- New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
- (2013) Ting Yang et al. Alzheimers & Dementia
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples
- (2013) Srinath Kasturirangan et al. BIOTECHNOLOGY PROGRESS
- Applying chaperones to protein-misfolding disorders: Molecular chaperones against α-synuclein in Parkinson's disease
- (2013) Ali Chaari et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
- (2013) David J. Irwin et al. NATURE REVIEWS NEUROSCIENCE
- Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
- (2013) Joohyun Park et al. NEUROBIOLOGY OF DISEASE
- A role for tau at the synapse in Alzheimer's disease pathogenesis
- (2013) Amy M. Pooler et al. NEUROPHARMACOLOGY
- Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
- (2013) Jens Moreth et al. Frontiers in Aging Neuroscience
- Plasma amyloid-β oligomers level is a biomarker for Alzheimer’s disease diagnosis
- (2012) L. Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
- (2012) M Di Carlo et al. JOURNAL OF PHYSICS-CONDENSED MATTER
- CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease
- (2011) Michael R. Sierks et al. Integrative Biology
- Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
- (2010) Min S Wang et al. BMC NEUROSCIENCE
- Molecular mechanisms of neurodegeneration in Alzheimer's disease
- (2010) L. Crews et al. HUMAN MOLECULAR GENETICS
- Specificity and sensitivity of the Abeta oligomer ELISA
- (2010) Andrea C. Klaver et al. JOURNAL OF NEUROSCIENCE METHODS
- Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form
- (2010) Srinath Kasturirangan et al. NEUROBIOLOGY OF AGING
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
- (2009) Thomas G. Beach et al. ACTA NEUROPATHOLOGICA
- Glutathione—a review on its role and significance in Parkinson’s disease
- (2009) Heather L. Martin et al. FASEB JOURNAL
- Detecting Morphologically Distinct Oligomeric Forms of α-Synuclein
- (2009) Sharareh Emadi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007
- (2008) Thomas G. Beach et al. CELL AND TISSUE BANKING
- Anti-oligomeric Aβ Single-chain Variable Domain Antibody Blocks Aβ-induced Toxicity Against Human Neuroblastoma Cells
- (2008) Andleeb Zameer et al. JOURNAL OF MOLECULAR BIOLOGY
- Characterisation of two antibodies to oligomeric Aβ and their use in ELISAs on human brain tissue homogenates
- (2008) Zoë van Helmond et al. JOURNAL OF NEUROSCIENCE METHODS
- The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons
- (2008) Roxana C. Sinjoanu et al. NEUROCHEMISTRY INTERNATIONAL
- Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death
- (2008) R. Resende et al. NEUROSCIENCE
- Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
- (2008) Igor F. Tsigelny et al. PLoS One
- Human-based studies on α-synuclein deposition and relationship to Parkinson's disease symptoms
- (2007) Glenda M. Halliday et al. EXPERIMENTAL NEUROLOGY
- An scFv Intrabody against the Nonamyloid Component of α-Synuclein Reduces Intracellular Aggregation and Toxicity
- (2007) Sandra M. Lynch et al. JOURNAL OF MOLECULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started